Biosafety Level 3 Core
Biosafety Level 3 Core
批准号:
8697515
负责人:
DANIEL Garrett KAVANAGH
金额:
$10.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Acquired Immunodeficiency SyndromeAddressAfricaAnimalsAreaAsiaBiologyBostonCaribbean regionCell SeparationCellsCertificationCollaborationsCommunicable DiseasesCommunitiesConsultationsContainmentDevelopmentDiseaseEnvironmentEpidemicEquipmentFacultyFlow CytometryFortuneFosteringFoundationsFutureHIVHIV InfectionsHome environmentHumanImageImmunologyInfectionInstitutesInstructionInternationalJournalsLaboratoriesLeadLeadershipLifeMicrobiologyMicroscopyMolecularMorbidity - disease rateMusPathogenesisPlayPopulationPreventionProceduresPublicationsResearchResearch InfrastructureResearch PersonnelResourcesRiskRoleSafetyScientistSouth AfricaSouth AmericaStrategic PlanningTalentsTimeTrainingTraining and EducationUniversitiesVoiceVotingWorkanimal facilitybiocontainment facilitybiosafety level 3 facilitycellular imagingdesignexperienceflexibilityglobal healthinnovationinsightinstrumentinstrumentationmeetingsmembermortalitymouse modelprogramsresearch facilityresearch studysquare footsymposiumtissue cultureworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The intersection of TB and HIV infection is increasing the global burden of both diseases. HIV infection
greatly increases the risk of TB converting from latent to active infection, and TB infection increases
morbidity and mortality in the HIV+ population. In 2006, the HU CFAR sponsored a national meeting on TBHIV
coinfection, which led to the creation of a working group of HU CFAR members focused onTB-HlV
research, and identification of a major unmet need: a BSL-3 biocontainment facility that would allow for cell
sorting and imaging. When new facilities for the Ragon Institute were being constructed, the HU CFAR
Membership successfully petitioned the Phillip T and Susan M Ragon Foundation to include a state of the art
BSL-3 laboratory to meet these needs. These recently completed facilities include 2240 square feet of BSL-
3 level space, flow cytometry and cell sorting, animal handling, imaging and additional space to
accommodate temporary equipment. With HU CFAR support this facility is now home of a newly created HU
CFAR BSL-3 Core. Dr. Daniel Kavanagh serves as the PI, working closely with Dr Sarah Fortune, an
internationally recognized expert in studies of TB who serves as Director of the newly-created Ragon TB
Program, with close interactions with the HU CFAR TB-HIV Scientific Working Group. Drs. Fortune and
Kavanagh jointly supervise a team of fellows, staff scientists, and a facility manager who bring extensive
experience in safe and productive of BSL-3-level research. The combined talents of this team, as well as
state-of-the-art BSL-3 facilities, are, available to the HU CFAR community. HU CFAR users are offered
training and certification to conduct experiments within the facility; alternatively Core staff are available to
carry out standard tissue culture and microbiology procedures on behalf of researchers who do not wish to
work inside the facility. The proposed HU CFAR Biosafety Level 3 Core is guided by the following specific
aims:
1. Provide training and consultation for members of HU CFAR community members who are planning
TB related projects
2. Provide access to BSL-3 microbiology, tissue culture, live cell microscopy, live FACS, animal
facilities, and special projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HLA restriction and TCR affinity in HIV
-
批准号:8298440
-
项目类别:
-
资助金额:$43.88万
-
财政年份:2011
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
Development of needle-free, vectorless, RNA-based vaccines for HIV
-
批准号:7896609
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2009
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
Development of needle-free, vectorless, RNA-based vaccines for HIV
-
批准号:7755138
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2009
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
The T cell response to rapidly evolving HIV antigens
-
批准号:7062425
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2004
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
The T cell response to rapidly evolving HIV antigens
-
批准号:6740059
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2004
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
The T cell response to rapidly evolving HIV antigens
-
批准号:6913659
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2004
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
Biosafety Level 3 Core
-
批准号:9111797
-
项目类别:
-
资助金额:$10.25万
-
财政年份:--
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
Biosafety Level 3 Core
-
批准号:8883332
-
项目类别:
-
资助金额:$10.47万
-
财政年份:--
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
Biosafety Level 3 Core
-
批准号:9317422
-
项目类别:
-
资助金额:$8.81万
-
财政年份:--
-
负责人:DANIEL Garrett KAVANAGH
-
依托单位:
海外基金